NUS Gross Profit from 2010 to 2024

NUS Stock

USD 7.55 0.33 4.57%

Nu Skin Gross Profit yearly trend continues to be comparatively stable with very little volatility. Gross Profit is likely to outpace its year average in 2024. Gross Profit is the profit Nu Skin Enterprises makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

1995-03-31

Previous Quarter

307.2 M

Current Value

301.5 M

Quarterly Volatility

146.5 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Nu Skin financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nu Skin's main balance sheet or income statement drivers, such as Depreciation And Amortization of 51.2 M, Interest Expense of 26.4 M or Total Revenue of 1.8 B, as well as many indicators such as Price To Sales Ratio of 0.47, Dividend Yield of 0.0844 or PTB Ratio of 1.12. NUS financial statements analysis is a perfect complement when working with Nu Skin Valuation or Volatility modules.

Check out the analysis of Nu Skin Correlation against competitors.

Latest Nu Skin's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Nu Skin Enterprises over the last few years. Gross profit is a required income statement account that reflects total revenue of Nu Skin Enterprises minus its cost of goods sold. It is profit before Nu Skin operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Nu Skin's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nu Skin's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 1.59 B

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Gross Profit

Timeline

NUS Gross Profit Regression Statistics

	Arithmetic Mean	1,713,091,930
	Geometric Mean	1,574,482,666
	Coefficient Of Variation	30.25
	Mean Deviation	336,457,551
	Median	1,777,021,000
	Standard Deviation	518,177,816
	Sample Variance	268508.2T
	Range	2.4B
	R-Value	0.12
	Mean Square Error	284922.9T
	R-Squared	0.01
	Significance	0.67
	Slope	14,030,274
	Total Sum of Squares	3759115.5T

NUS Gross Profit History

	2024	1.4 B
	2023	1.4 B
	2022	1.6 B
	2021	2 B
	2020	1.9 B
	2019	1.8 B
	2018	2 B

Other Fundumenentals of Nu Skin Enterprises

Gross Profit Margin

Nu Skin Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Good Will	Intangible Assets	Common Stock	Long Term Debt	Property Plant Equipment	Current Deferred Revenue	Short Term Investments	Treasury Stock	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock	Long Term Investments
Total Assets		0.96	0.22	0.96	0.76	0.62	0.97	0.91	0.16	0.56	-0.19	-0.36	0.44	0.91	-0.54	0.26	-0.8	0.89	0.57	0.76	-0.26	-0.07	0.37	0.29	0.09	0.26
Total Stockholder Equity	0.96		0.15	0.91	0.66	0.54	0.87	0.89	0.11	0.46	-0.25	-0.44	0.31	0.87	-0.62	0.26	-0.68	0.91	0.41	0.66	-0.21	-0.09	0.3	0.24	0.13	0.21
Net Debt	0.22	0.15		0.38	-0.18	0.43	0.26	-0.13	-0.01	0.71	0.14	0.51	0.89	0.31	0.08	-0.38	-0.67	0.44	0.78	0.74	-0.7	-0.64	0.87	0.8	-0.66	0.73
Retained Earnings	0.96	0.91	0.38		0.61	0.5	0.94	0.77	0.18	0.64	-0.25	-0.3	0.55	0.93	-0.47	0.08	-0.88	0.85	0.69	0.84	-0.31	-0.14	0.44	0.35	0.1	0.35
Accounts Payable	0.76	0.66	-0.18	0.61		0.62	0.79	0.88	0.07	0.27	-0.02	-0.4	0.14	0.53	-0.41	0.64	-0.47	0.55	0.28	0.4	-0.09	0.11	0.14	0.1	0.14	0.08
Net Receivables	0.62	0.54	0.43	0.5	0.62		0.64	0.57	-0.21	0.54	0.34	0.21	0.63	0.47	-0.37	0.37	-0.57	0.74	0.56	0.65	-0.63	-0.41	0.67	0.62	-0.59	0.43
Total Liab	0.97	0.87	0.26	0.94	0.79	0.64		0.87	0.19	0.61	-0.12	-0.28	0.52	0.9	-0.44	0.25	-0.84	0.82	0.66	0.81	-0.29	-0.05	0.42	0.32	0.06	0.28
Total Current Assets	0.91	0.89	-0.13	0.77	0.88	0.57	0.87		0.21	0.26	-0.23	-0.51	0.15	0.78	-0.59	0.48	-0.56	0.76	0.27	0.48	-0.01	0.13	0.1	0.03	0.19	0.03
Short Term Debt	0.16	0.11	-0.01	0.18	0.07	-0.21	0.19	0.21		0.06	-0.28	-0.12	-0.07	0.25	0.26	0.08	-0.23	0.09	-0.09	0.15	0.53	0.25	0.01	-0.31	0.19	0.17
Good Will	0.56	0.46	0.71	0.64	0.27	0.54	0.61	0.26	0.06		0.34	0.24	0.68	0.5	0.16	-0.06	-0.74	0.6	0.78	0.9	-0.59	-0.46	0.85	0.72	-0.2	0.62
Intangible Assets	-0.19	-0.25	0.14	-0.25	-0.02	0.34	-0.12	-0.23	-0.28	0.34		0.62	0.07	-0.28	0.29	0.09	0.21	-0.04	0.07	0.09	-0.24	-0.24	0.28	0.14	-0.32	0.09
Common Stock	-0.36	-0.44	0.51	-0.3	-0.4	0.21	-0.28	-0.51	-0.12	0.24	0.62		0.36	-0.23	0.41	-0.27	0.1	-0.05	0.25	0.18	-0.39	-0.6	0.41	0.3	-0.67	0.44
Long Term Debt	0.44	0.31	0.89	0.55	0.14	0.63	0.52	0.15	-0.07	0.68	0.07	0.36		0.51	-0.17	-0.29	-0.81	0.54	0.92	0.81	-0.71	-0.49	0.82	0.79	-0.64	0.62
Property Plant Equipment	0.91	0.87	0.31	0.93	0.53	0.47	0.9	0.78	0.25	0.5	-0.28	-0.23	0.51		-0.5	-0.02	-0.8	0.84	0.62	0.77	-0.25	-0.05	0.3	0.23	0.08	0.2
Current Deferred Revenue	-0.54	-0.62	0.08	-0.47	-0.41	-0.37	-0.44	-0.59	0.26	0.16	0.29	0.41	-0.17	-0.5		-0.07	0.27	-0.51	-0.13	-0.12	0.01	-0.02	0.11	0.05	0.07	0.09
Short Term Investments	0.26	0.26	-0.38	0.08	0.64	0.37	0.25	0.48	0.08	-0.06	0.09	-0.27	-0.29	-0.02	-0.07		0.04	0.18	-0.25	-0.06	0.08	0.18	-0.06	-0.16	0.08	-0.04
Treasury Stock	-0.8	-0.68	-0.67	-0.88	-0.47	-0.57	-0.84	-0.56	-0.23	-0.74	0.21	0.1	-0.81	-0.8	0.27	0.04		-0.74	-0.84	-0.91	0.48	0.23	-0.7	-0.61	0.22	-0.53
Net Tangible Assets	0.89	0.91	0.44	0.85	0.55	0.74	0.82	0.76	0.09	0.6	-0.04	-0.05	0.54	0.84	-0.51	0.18	-0.74		0.56	0.81	-0.44	-0.38	0.57	0.47	-0.24	0.47
Long Term Debt Total	0.57	0.41	0.78	0.69	0.28	0.56	0.66	0.27	-0.09	0.78	0.07	0.25	0.92	0.62	-0.13	-0.25	-0.84	0.56		0.88	-0.65	-0.44	0.73	0.71	-0.36	0.56
Capital Surpluse	0.76	0.66	0.74	0.84	0.4	0.65	0.81	0.48	0.15	0.9	0.09	0.18	0.81	0.77	-0.12	-0.06	-0.91	0.81	0.88		-0.59	-0.45	0.81	0.68	-0.28	0.64
Short Long Term Debt	-0.26	-0.21	-0.7	-0.31	-0.09	-0.63	-0.29	-0.01	0.53	-0.59	-0.24	-0.39	-0.71	-0.25	0.01	0.08	0.48	-0.44	-0.65	-0.59		0.55	-0.69	-0.87	0.54	-0.41
Cash And Equivalents	-0.07	-0.09	-0.64	-0.14	0.11	-0.41	-0.05	0.13	0.25	-0.46	-0.24	-0.6	-0.49	-0.05	-0.02	0.18	0.23	-0.38	-0.44	-0.45	0.55		-0.66	-0.65	0.58	-0.81
Net Invested Capital	0.37	0.3	0.87	0.44	0.14	0.67	0.42	0.1	0.01	0.85	0.28	0.41	0.82	0.3	0.11	-0.06	-0.7	0.57	0.73	0.81	-0.69	-0.66		0.89	-0.64	0.83
Net Working Capital	0.29	0.24	0.8	0.35	0.1	0.62	0.32	0.03	-0.31	0.72	0.14	0.3	0.79	0.23	0.05	-0.16	-0.61	0.47	0.71	0.68	-0.87	-0.65	0.89		-0.58	0.67
Capital Stock	0.09	0.13	-0.66	0.1	0.14	-0.59	0.06	0.19	0.19	-0.2	-0.32	-0.67	-0.64	0.08	0.07	0.08	0.22	-0.24	-0.36	-0.28	0.54	0.58	-0.64	-0.58		-0.55
Long Term Investments	0.26	0.21	0.73	0.35	0.08	0.43	0.28	0.03	0.17	0.62	0.09	0.44	0.62	0.2	0.09	-0.04	-0.53	0.47	0.56	0.64	-0.41	-0.81	0.83	0.67	-0.55

Click cells to compare fundamentals

About Nu Skin Financial Statements

Nu Skin shareholders use historical fundamental indicators, such as Gross Profit, to determine how well the company is positioned to perform in the future. Although Nu Skin investors may analyze each financial statement separately, they are all interrelated. The changes in Nu Skin's assets and liabilities, for example, are also reflected in the revenues and expenses on on Nu Skin's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Gross Profit	1.4 B	1.4 B
Gross Profit Margin	0.69	0.87

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for NUS Stock Analysis

When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC